Hepatocellular Carcinoma
Conditions
Interventions
Treatment-naive HCC patients who completed MDT:None
Sponsors
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients with HCC confirmed by pathology or imaging; 2.Treatment-naive patients without any anti-tumor therapy prior to MDT consultation; 3.Complete and traceable written MDT treatment plans; 4.Integral clinical medical records, laboratory examinations, imaging data, treatment records and follow-up information. 5. Age = 18 years.
Exclusion criteria
Exclusion criteria: 1.Recurrent HCC and de novo HCC after liver transplantation; 2.Patients with MDT recommendations merely for regular surveillance without definite anti-tumor regimens; 3.Patients who received anti-tumor therapy at external hospitals before MDT consultation, those treated entirely in other medical centers, cases with missing core clinical data, or patients completely lost to follow-up; 4.Combined hepatocellular-cholangiocarcinoma and metastatic hepatic malignancies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| MDT plan compliance rate under the dual guideline system; MDT adherence rate among different stratified populations; | — |
Countries
China
Contacts
Public ContactGui Honglian
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Outcome results
None listed